Market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights are among the key offerings featured in The Business Research Company’s 2026 market reports, designed to deliver more actionable and strategically valuable research.
Artificial Intelligence In Cancer Diagnostics Market Size Estimate For 2026 And Revenue Forecast Through 2030
The artificial intelligence in cancer diagnostics market size has seen significant expansion in recent years. It is projected to increase from $0.52 billion in 2025 to $0.69 billion in 2026, registering a compound annual growth rate (CAGR) of 31.3%. This growth in previous periods stemmed from factors such as the rising volume of medical imaging data, the early adoption of computer-aided diagnosis, increasing cancer prevalence, advancements in imaging technologies, and enhanced healthcare digitization.
The artificial intelligence in cancer diagnostics market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $2.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 30.9%. Factors contributing to this growth during the forecast period include a rising demand for early cancer detection, the increasing adoption of precision medicine, enhancements in diagnostic accuracy powered by AI, increased funding for oncology research, and the integration of genomic and imaging data. Key trends anticipated during this period involve AI-assisted analysis of medical imaging, the development of advanced early cancer detection tools, the incorporation of predictive oncology analytics, the automation of diagnostic processes, and the growing uptake of decision support systems.
Free Artificial Intelligence In Cancer Diagnostics Market Report Sample Available For Download:
Why Is Demand In The Artificial Intelligence In Cancer Diagnostics Market Expected To Keep Rising?
The increasing incidence of cancer is anticipated to drive the expansion of artificial intelligence within the cancer diagnostics market. Cancer, characterized by uncontrolled cellular proliferation, affects multiple organs and is a major cause of illness and death globally. Artificial intelligence finds application in cancer diagnostics to enable precise and efficient analysis of medical imagery, facilitating early identification and accurate categorization of malignant growths. For instance, the American Cancer Society, a US-based non-profit, indicated in January 2025 that the United States is forecast to see 2,041,910 new cancer diagnoses and 618,120 cancer-related fatalities in 2025. Additionally, the World Health Organisation, an Intergovernmental body based in Switzerland, reported in February 2024 that around 20 million new cancer cases were documented in 2022, resulting in 9.7 million deaths, with an estimated 53.5 million people alive within five years of their cancer diagnosis. Consequently, the growing occurrence of cancer is set to boost the development of artificial intelligence in the cancer diagnostics market.
How Is The Artificial Intelligence In Cancer Diagnostics Market Divided Across Segments And Subsegments?
The artificial intelligence in cancer diagnostics market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization
Subsegments:
1) By Software Solutions: Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms
2) By Hardware: Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure
3) By Services: Consulting Services, Implementation Services, Maintenance And Support Services, Training Services
Artificial Intelligence In Cancer Diagnostics Market Trends Reshaping Customer Demand And Business Strategies
Leading firms within the artificial intelligence in cancer diagnostics market are prioritizing strategic collaborations to accelerate the adoption of AI-driven digital pathology solutions for assisting in cancer diagnosis. These alliances involve companies utilizing their respective strengths and assets to gain reciprocal advantages and achieve common goals. As an illustration, during October 2023, F. Hoffmann-La Roche AG, a diagnostics and pharmaceutical entity based in Switzerland, revealed its partnership with Ibex Medical Analytics, an Israeli medical technology firm, and Amazon Web Services, Inc., a widely utilized US-based cloud provider. This collaboration enables pathology laboratories to leverage the navify Digital Pathology software platform, gaining access to Ibex’s AI-powered decision support tools to help clinicians in detecting breast and prostate cancer. The joint effort between Ibex Medical Analytics and Roche is developing groundbreaking AI-enabled methodologies, supporting pathologists and labs in fully realizing the potential of digital transformation. These cloud-based digital pathology and AI solutions from Roche and Ibex are powered by Amazon Web Services (AWS), providing a scalable and sustainable infrastructure for pathology laboratories.
Artificial Intelligence In Cancer Diagnostics Market Major Players: Companies At The Forefront Of The Industry
Major companies operating in the artificial intelligence in cancer diagnostics market are Microsoft Corporation; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
Read More About The Artificial Intelligence In Cancer Diagnostics Market In The Full Report:
Artificial Intelligence In Cancer Diagnostics Market Regional Share Analysis For 2025
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
